Electromed (ELMD) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$73.8M

Revenue (quarter)

$19.4M

Revenue growth (year over year)

+11.64%

Gross profit (trailing twelve months)

$57.9M

Gross margin

78.54%

Net income (trailing twelve months)

$11.3M

Net income (quarter)

$3.4M

Net income growth (year over year)

+54.31%

Net margin

15.32%

Return on equity

23.26%

EPS (trailing twelve months)

$1.37

Book value per share

$6.45

P/E (trailing twelve months)

19.99

Price to book

4.19

Debt to assets

18.54%

Payout ratio

—

Dividend yield

—

Company profile

Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.

• Is Electromed (ELMD) profitable?

  Yes. Electromed earned $11.3M in net income over the trailing twelve months, a net margin of 15.32%.

• How much revenue does Electromed (ELMD) make?

  Electromed generated $73.8M in revenue over the trailing twelve months, up 11.64% year over year.

• What is ELMD's P/E ratio?

  Electromed trades at 20.0 times trailing twelve-month earnings, on an EPS of $1.37.

• How do I buy stock in Electromed (ELMD)?

  ELMD trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.